Embecta Shares Gain As Q1 Earnings Exceed Expectations
Embecta Corp (NASDAQ:EMBC) posted Q1 FY23 revenues of $275.7 million, down 4.7% on a reported basis and up 0.7% on…
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell
• WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
Morgan Stanley Maintains Equal-Weight on Embecta, Lowers Price Target to $31
Morgan Stanley analyst Cecilia Furlong maintains Embecta (NASDAQ:EMBC) with a Equal-Weight and lowers the price target from $33 to $31.
Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance
Embecta Corp (NASDAQ:EMBC) posted Q4 revenues of $274.6 million, down 8.7% on a reported basis and down 4.2% on a…
Earnings Scheduled For December 20, 2022
Companies Reporting Before The Bell
• Treasure Global (NASDAQ:TGL) is likely to report earnings for its first quarter.
Intuity Medical And Embecta Launch Commercial Collaboration, Expanding Access To Self-management Innovations For People With Diabetes
Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ:EMBC) today announced they have signed a co-promotional agreement under which embecta sales representatives will be able to promote Intuity
